KRYS - Krystal Biotech Inc Stock Price, Fair Value and News

213.26USD+2.57 (+1.22%)Market Closed

Market Summary

USD213.26+2.57

Market Closed

1.22%

KRYS Stock Price

View Fullscreen

KRYS RSI Chart

KRYS Valuation

Market Cap

6.1B

Price/Earnings (Trailing)

106.55

Price/Sales (Trailing)

116.71

EV/EBITDA

305.33

Price/Free Cashflow

-111.88

KRYS Price/Sales (Trailing)

KRYS Profitability

EBT Margin

25.44%

Return on Equity

7.15%

Return on Assets

6.7%

Free Cashflow Yield

-0.89%

KRYS Fundamentals

KRYS Revenue

Revenue (TTM)

50.7M

Rev. Growth (Yr)

957.49%

Rev. Growth (Qtr)

7.37%

KRYS Earnings

Earnings (TTM)

57.2M

Earnings Growth (Yr)

102.06%

Earnings Growth (Qtr)

-89.28%

Breaking Down KRYS Revenue

Last 7 days

4.7%

Last 30 days

17.1%

Last 90 days

35.9%

Trailing 12 Months

75.9%

How does KRYS drawdown profile look like?

KRYS Financial Health

Current Ratio

12.66

KRYS Investor Care

Shares Dilution (1Y)

10.69%

Diluted EPS (TTM)

2.03

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	50.7M
2018	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Krystal Biotech Inc

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

CEO	Mr. Krish S. Krishnan M.B.A., M.S.
WEBSITE	krystalbio.com
INDUSTRY	Biotechnology
EMPLOYEES	210

Krystal Biotech Inc Frequently Asked Questions

What is the ticker symbol for Krystal Biotech Inc? What does KRYS stand for in stocks?

KRYS is the stock ticker symbol of Krystal Biotech Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Krystal Biotech Inc (KRYS)?

As of Fri Jul 26 2024, market cap of Krystal Biotech Inc is 6.09 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KRYS stock?

You can check KRYS's fair value in chart for subscribers.

Is Krystal Biotech Inc a good stock to buy?

The fair value guage provides a quick view whether KRYS is over valued or under valued. Whether Krystal Biotech Inc is cheap or expensive depends on the assumptions which impact Krystal Biotech Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KRYS.

What is Krystal Biotech Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, KRYS's PE ratio (Price to Earnings) is 106.55 and Price to Sales (PS) ratio is 116.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KRYS PE ratio will change depending on the future growth rate expectations of investors.